Nita K. Lee

1.8k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

Nita K. Lee is a scholar working on Oncology, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Nita K. Lee has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Obstetrics and Gynecology and 8 papers in Epidemiology. Recurrent topics in Nita K. Lee's work include Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Nita K. Lee is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Nita K. Lee collaborates with scholars based in United States and United Kingdom. Nita K. Lee's co-authors include Gini F. Fleming, Ricardo R. Lastra, John W. Moroney, K. Tatebe, Rebecca Brooks, Christina H. Son, S. Diane Yamada, Yasmin Hasan, Daniel S. Kapp and Michael K. Cheung and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Nita K. Lee

37 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current recommendations and recent progress in endometrial cancer

2019 425 citations Gini F. Fleming, Nita K. Lee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nita K. Lee United States	14	496	283	279	213	204	39	1.1k
Katina Robison United States	18	351 0.7×	452 1.6×	192 0.7×	129 0.6×	126 0.6×	75	1.1k
Eloise Chapman‐Davis United States	22	383 0.8×	482 1.7×	549 2.0×	222 1.0×	196 1.0×	95	1.6k
Lindsay M. Kuroki United States	16	224 0.5×	269 1.0×	368 1.3×	358 1.7×	222 1.1×	81	1.3k
Matthew Schlumbrecht United States	19	221 0.4×	295 1.0×	325 1.2×	221 1.0×	104 0.5×	110	1.0k
Allison Gockley United States	18	431 0.9×	556 2.0×	295 1.1×	148 0.7×	85 0.4×	66	1.1k
Brittany A. Davidson United States	17	346 0.7×	356 1.3×	480 1.7×	100 0.5×	131 0.6×	90	1.2k
Corrado Terranova Italy	23	620 1.3×	672 2.4×	239 0.9×	199 0.9×	132 0.6×	74	1.4k
William J. Lowery United States	17	487 1.0×	640 2.3×	295 1.1×	130 0.6×	91 0.4×	38	1.4k
Tim Mould United Kingdom	17	483 1.0×	398 1.4×	171 0.6×	163 0.8×	80 0.4×	48	980
Signe Opdahl Norway	27	256 0.5×	357 1.3×	437 1.6×	249 1.2×	315 1.5×	75	1.7k

Countries citing papers authored by Nita K. Lee

Since Specialization

Citations

This map shows the geographic impact of Nita K. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nita K. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nita K. Lee more than expected).

Fields of papers citing papers by Nita K. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nita K. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nita K. Lee. The network helps show where Nita K. Lee may publish in the future.

Co-authorship network of co-authors of Nita K. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Nita K. Lee. A scholar is included among the top collaborators of Nita K. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nita K. Lee. Nita K. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurnit, Katherine C., S. Diane Yamada, Nita K. Lee, et al.. (2025). Successful treatment of gynecologic malignancy with trastuzumab deruxtecan in three patients with HER2 mutations. Gynecologic Oncology Reports. 62. 101974–101974.

Ackroyd, Sarah, et al.. (2025). Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center. Gynecologic Oncology. 201. 203–209.

Fadiel, Ahmed, et al.. (2024). Utilizing geospatial artificial intelligence to map cancer disparities across health regions. Scientific Reports. 14(1). 7693–7693. 5 indexed citations

Vu, Milkie, Kelly Boyd, Emilia H. De Marchis, et al.. (2023). Perceived Appropriateness of Assessing for Health-related Socioeconomic Risks Among Adult Patients with Cancer. Cancer Research Communications. 3(4). 521–531. 6 indexed citations

Lee, Nita K., et al.. (2023). A usability and participatory design study for GeRI, an open-source, remote cancer treatment toxicity and frailty monitoring platform for older adults. Journal of Geriatric Oncology. 15(1). 101595–101595. 5 indexed citations

Lee, Nita K., Jasmin A. Tiro, & Kunle Odunsi. (2023). Disparities in Gynecologic Cancers. The Cancer Journal. 29(6). 343–353. 1 indexed citations

Ackroyd, Sarah, et al.. (2022). Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19. Gynecologic Oncology Reports. 41. 100986–100986. 4 indexed citations

Lindau, Stacy Tessler, Jennifer A. Makelarski, Kelly Boyd, et al.. (2021). Change in Health-Related Socioeconomic Risk Factors and Mental Health During the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women. Journal of Women s Health. 30(4). 502–513. 35 indexed citations

Kacew, Alec, Anand Patel, Fay J. Hlubocky, et al.. (2021). Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers. Journal of Adolescent and Young Adult Oncology. 11(3). 284–289. 7 indexed citations

10.

Ackroyd, Sarah, Elbert S. Huang, Katherine C. Kurnit, & Nita K. Lee. (2021). Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecologic Oncology. 162(2). 249–255. 24 indexed citations

11.

Vu, Milkie, Jennifer A. Makelarski, Sadia Haider, et al.. (2021). Racial and Ethnic Disparities in Health-Related Socioeconomic Risks During the Early COVID-19 Pandemic: A National Survey of U.S. Women. Journal of Women s Health. 30(10). 1375–1385. 8 indexed citations

12.

Hoppenot, Claire, Fay J. Hlubocky, Julie Chor, S. Diane Yamada, & Nita K. Lee. (2021). Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study. Supportive Care in Cancer. 30(1). 367–376. 8 indexed citations

13.

Hoppenot, Claire, Fay J. Hlubocky, Julie Chor, S. Diane Yamada, & Nita K. Lee. (2020). Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives. JCO Oncology Practice. 16(8). 483–489. 6 indexed citations

14.

DeRosa, Branlyn Werba, Alexandra K. Zaleta, Kelly Clark, et al.. (2020). Experience of financial burden and distress among people with ovarian cancer.. Journal of Clinical Oncology. 38(15_suppl). e19400–e19400. 1 indexed citations

15.

Hoppenot, Claire, et al.. (2019). Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?. Gynecologic Oncology. 154(1). 177–182. 9 indexed citations

16.

Escamilla, Verónica, et al.. (2018). Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community. Gynecologic Oncology. 152(2). 322–327. 6 indexed citations

17.

Hunn, J., Meaghan Tenney, Ana I. Tergas, et al.. (2015). Patterns and utility of routine surveillance in high grade endometrial cancer. Gynecologic Oncology. 137(3). 485–489. 23 indexed citations

18.

Buell‐Gutbrod, Rebecca, et al.. (2014). Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2). International Journal of Gynecological Pathology. 34(1). 65–73. 16 indexed citations

19.

Matulonis, Ursula A., Julie Lee, William P. Tew, et al.. (2012). ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. European Journal of Cancer. 49(1). 121–131. 39 indexed citations

20.

Lee, Nita K.. (2011). Adjuvant Treatment of Advanced-stage Endometrial Cancer. Clinical Obstetrics & Gynecology. 54(2). 256–265. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact